Physician profile
Caitlin Mccarry
NPI 1245091958
$3,815.67
in general payments reported to CMS, 2019-2025
17 companies · $1,676 in 2025
The $1,676 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,140 · 2025: $1,676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,270 · Consulting Fee: $375 · Education: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,269.67 |
| Consulting Fee | $375.00 |
| Education | $171.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $652.31 | 2024 | Bimzelx |
| Abbvie INC. | $637.02 | 2024-2025 | |
| Incyte Corporation | $551.43 | 2024-2025 | Opzelura, Opzelura |
| Janssen Biotech, INC. | $508.29 | 2024-2025 | Tremfya |
| Amgen INC. | $293.05 | 2024-2025 | Otezla |
| Regeneron Healthcare Solutions, INC. | $241.63 | 2024 | Dupixent |
| Novartis Pharmaceuticals Corporation | $167.45 | 2024 | |
| Lilly USA, LLC | $146.33 | 2024 | Olumiant, Taltz, Ebglyss |
| Journey Medical Corporation | $125.00 | 2025 | |
| Dermavant Sciences, INC. | $120.54 | 2024 | Vtama |
| Sanofi-Aventis U.S. LLC | $99.00 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $91.56 | 2024 | Sotyktu |
| Genzyme Corporation | $83.35 | 2024 | |
| Galderma Laboratories, L.P. | $41.22 | 2025 | |
| Verrica Pharmaceuticals INC. | $23.52 | 2024 | Ycanth |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $18.80 | 2025 | |
| Lnhc, INC | $15.17 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caitlin Mccarry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.